Aim: Candida infections develop especially in intensive care unit (ICU) patients and increase the mortality rates. So, early and accurate diagnosis of Candida infections and determination of risk factors are very important. We aimed to retrospectively investigate Candida infections in terms of species and risk factors for candidemia caused by fungi. Methods: Candida infections in critically ill patients hospitalized in the Intensive Care Unit of Bolu Abant Izzet Baysal University Training and Research Hospital between January 2014 and December 2018 were retrospectively analyzed. The isolated Candida species were evaluated according to the sample types. The cases were investigated in terms of mortality due to candidiasis, previously used antibiotics and isolated Candida species. Results: 34 Candida species isolated from fungal cultures in ICUs were included in the study. Candida albicans (73.5%) was the most prevalent species isolated (NAC 26.5%). Patients with Candida isolated in their urine samples (76%) had a higher mortality rate than patients with Candida from other regions. Conclusion: The results of our study suggest that the highest rate of candidiasis (88%) is in patients who received beta-lactam antibiotic treatment. In addition, we think that when Candida species are detected in the urine samples of critically ill patients in the ICU, care should be taken in terms of candidiasis.
 Haque M, Sartelli M, McKimm J, et al. Health care-associated infections - an overview. Infect Drug Resist. 2018;1:2321- 33.
 Yiş R, Doluca M. Identification of Candida species by restriction enzyme analysis. Turk J Med Sci. 2018;48(5):1058-67.
 Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014; 10:95-105.
 Atici S, Soysal A, Kepenekli Kadayifci E, et al. Healthcare-associated infections in a newly opened pediatric intensive care unit in Turkey: Results of four-year surveillance. J Infect Dev Ctries. 2016;10(3):254-59.
 Montagna MT, Lovero G, Borghi E, et al. Candidemia in intensive care unit: a nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013. Eur Rev Med Pharmacol Sci. 2014;18(5):661-74.
 Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309-32.
 Al-Dorzi HM, Sakkijha H, Khan R, et al. Invasive candidiasis in critically ıll patients: a prospective cohort study in two tertiary care centers. J Intensive Care Med. 2020;35(6):542-53.
 Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50(4):243-60.
 Alişkan HE, Bozkirli ED, Çolakoğlu Ş, et al. Evaluation of risk factors in candidemias caused by Candida albicans and nonalbicans Candida species, isolated from the blood cultures for three years period in our hospital. Turk Hij ve Deney Biyol Derg. 2016;73(1):15–24.
 Erdem F, Tuncer Ertem G, Oral B, et al. Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species. Mikrobiyol Bul. 2012;46(4):637-48.
 Çağan E, Soysal A, Bakır M. Childhood candida infections: single center experience. Cukurova Med J. 2015;40(2):245-51.
 Karaltı İ. Retrospective evaluation of candida species isolated from urine in a university hospital. The Journal of Fungus. 2018;9(1):76-79.
 Kılınçel Ö, Akar N, Karamurat ZD, et al. Distribution and antifungal susceptibility of candida species isolated from blood cultures. Türk Mikrobiyoloji Cem Derg. 2018;48(4):256–63.
 Savcı Ü, Yılmaz N. Distribution of Candida species isolated from various sample and antifungal resistance ratio. Turk J Clin Lab. 2017;8(3):85-90.
 Yapar N, Pullukcu H, Avkan-Oguz V, et al. Evaluation of species distribution and risk factors of candidemia: a multicenter casecontrol study. Med Mycol. 2011;49(1):26- 31.
 Sav H, Demir G, Atalay MA, et al. Evaluation of Candida strains isolated from clinical specimens. Turk Hij Den Biyol Derg. 2013;70(4):175-80.
 Pelit S, Uzun M. Investigation of species distribution and antifungal susceptibility of candida species isolated from various clinical samples from intensive care unit patients. Journal of Medical and Surgical Intensive Care Medicine. 2016;7(2):49-52.
 Jahagirdar VL, Davane MS, Aradhye SC, et al. Candida species as potential nosocomial pathogens - A review. Electron J Gen Med. 2018;15(2):em05.
 Büyüktuna SA, Hasbek M, Elaldı N, et al. Epidemiological analysis of Nosocomial Candida infections: Experience of a university hospital. Cumhur Med J. 2019;41(2):318–27.